1
|
Abuyousef S, Alnaimi S, Omar NE, Elajez R, Elmekaty E, Abdelfattah-Arafa E, Barazi R, Ghasoub R, Rahhal A, Hamou F, Al-Amri M, Karawia A, Ajaj F, Alkhawaja R, Kardousha A, Awaisu A, Abou-Ali A, Khatib M, Aboukamar M, Al-Hail M. Early predictors of intensive care unit admission among COVID-19 patients in Qatar. Front Public Health 2024; 12:1278046. [PMID: 38572008 PMCID: PMC10987715 DOI: 10.3389/fpubh.2024.1278046] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/15/2023] [Accepted: 02/19/2024] [Indexed: 04/05/2024] Open
Abstract
Background COVID-19 is associated with significant morbidity and mortality. This study aimed to explore the early predictors of intensive care unit (ICU) admission among patients with COVID-19. Methods This was a case-control study of adult patients with confirmed COVID-19. Cases were defined as patients admitted to ICU during the period February 29-May 29, 2020. For each case enrolled, one control was matched by age and gender. Results A total of 1,560 patients with confirmed COVID-19 were included. Each group included 780 patients with a predominant male gender (89.7%) and a median age of 49 years (interquartile range = 18). Predictors independently associated with ICU admission were cardiovascular disease (adjusted odds ratio (aOR) = 1.64, 95% confidence interval (CI): 1.16-2.32, p = 0.005), diabetes (aOR = 1.52, 95% CI: 1.08-2.13, p = 0.016), obesity (aOR = 1.46, 95% CI: 1.03-2.08, p = 0.034), lymphopenia (aOR = 2.69, 95% CI: 1.80-4.02, p < 0.001), high AST (aOR = 2.59, 95% CI: 1.53-4.36, p < 0.001), high ferritin (aOR = 1.96, 95% CI: 1.40-2.74, p < 0.001), high CRP (aOR = 4.09, 95% CI: 2.81-5.96, p < 0.001), and dyspnea (aOR = 2.50, 95% CI: 1.77-3.54, p < 0.001). Conclusion Having cardiovascular disease, diabetes, obesity, lymphopenia, dyspnea, and increased AST, ferritin, and CRP were independent predictors for ICU admission in patients with COVID-19.
Collapse
Affiliation(s)
- Safae Abuyousef
- Department of Pharmacy, Heart Hospital, Hamad Medical Corporation, Doha, Qatar
| | - Shaikha Alnaimi
- Department of Pharmacy, Hamad Bin Khalifa Medical City, Hamad Medical Corporation, Doha, Qatar
| | - Nabil E. Omar
- Department of Pharmacy, National Centre for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar
- Health Sciences Program, Clinical and Population Health Research, College of Pharmacy, Qatar University, Doha, Qatar
| | - Reem Elajez
- Department of Pharmacy, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar
| | - Eman Elmekaty
- Department of Pharmacy, Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar
| | | | - Raja Barazi
- Department of Pharmacy, Al Wakra Hospital, Hamad Medical Corporation, Doha, Qatar
| | - Rola Ghasoub
- Department of Pharmacy, National Centre for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar
| | - Ala Rahhal
- Department of Pharmacy, Heart Hospital, Hamad Medical Corporation, Doha, Qatar
| | - Fatima Hamou
- Department of Pharmacy, Heart Hospital, Hamad Medical Corporation, Doha, Qatar
| | - Maha Al-Amri
- Department of Pharmacy, Heart Hospital, Hamad Medical Corporation, Doha, Qatar
| | - Ahmed Karawia
- Department of Pharmacy, Rumailah Hospital, Hamad Medical Corporation, Doha, Qatar
| | - Fatima Ajaj
- Department of Pharmacy, Home Health Care, Hamad Medical Corporation, Doha, Qatar
| | - Raja Alkhawaja
- Department of Pharmacy, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar
| | - Ahmed Kardousha
- Department of Pharmacy, National Centre for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar
| | - Ahmed Awaisu
- College of Pharmacy, QU Health, Qatar University, Doha, Qatar
| | - Adel Abou-Ali
- Astellas Pharma Global Development, Inc., Northbrook, IL, United States
| | - Mohamad Khatib
- Department of Critical Care, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar
| | - Mohammed Aboukamar
- Department of Infectious Disease, Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar
| | - Moza Al-Hail
- Department of Pharmacy, Women’s Wellness and Research Center, Hamad Medical Corporation, Doha, Qatar
| |
Collapse
|
2
|
Alhmoud E, Barazi R, Saad M, Al Khiyami D, El Ajez R, Bakdach D, Omrani A, Ibrahim W, El Anany R, Al-Hail M. Characteristics and outcomes of adult patients with asthma presenting with COVID-19: A comparative cohort study. Qatar Med J 2023; 2023:15. [PMID: 37565045 PMCID: PMC10411356 DOI: 10.5339/qmj.2023.15] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/11/2022] [Accepted: 05/10/2023] [Indexed: 08/12/2023] Open
Abstract
BACKGROUND Bronchial asthma affects about 20% of Qatar's population. The impact of asthma on COVID-19 outcomes is controversial. The aim of this study was to explore the impact of asthma on COVID-19 outcomes and the predictors of COVID-19-related morbidity and mortality in a cohort of asthma patients infected by COVID-19. METHODS This is a retrospective cohort study of adult patients with asthma infected with COVID-19, who were recruited from Hamad Medical Corporation (HMC), the main healthcare system in Qatar. Patients were matched to a control group of non-asthmatic COVID-19 patients (1:2) based on sex, age, and other comorbidities. RESULTS Between March and August 2020, 616 patients with asthma met the inclusion criteria. The need for hospitalization among patients with asthma was independently associated with older age (adjusted odds ratio [aOR] for 10 years, 1.32; 95% confidence interval [CI], 1.13-1.54; p = 0.001) and hypertension (aOR, 2.4; 95% CI, 1.43-3.93; p = 0.001) but not with the use of inhaled corticosteroids (ICS), long-acting beta2 agonists, montelukast, or tiotropium. Patients with asthma required less hospitalization for COVID-19 than non-asthmatic patients (28.2% vs. 37.3%, respectively; aOR, 0.59; 95% CI, 0.77-0.90; p < 0.001). However, admission to the intensive care unit (ICU) was comparable between both groups (3.3% vs. 2.2%; aOR, 1.64; 95% CI, 0.78-3.43; p = 0.193). No difference in mortality rate was observed between the two groups. CONCLUSIONS In Qatar, adult patients with asthma do not appear to be at higher risk of COVID-19-related hospitalization or ICU admission compared to the general adult COVID-19-infected population. Older age and hypertension were the only significant predictors of COVID-19-related hospitalization among patients with asthma. Further larger studies are required to confirm such an association.
Collapse
Affiliation(s)
- Eman Alhmoud
- Pharmacy Department, Hamad Medical Corporation, Doha, Qatar. E-mail: ORCID: 0000-0002-3871-7088
| | - Raja Barazi
- Pharmacy Department, Hamad Medical Corporation, Doha, Qatar. E-mail: ORCID: 0000-0002-3871-7088
| | - Mohammed Saad
- Pharmacy Department, Hamad Medical Corporation, Doha, Qatar. E-mail: ORCID: 0000-0002-3871-7088
| | - Dania Al Khiyami
- Pharmacy Department, Hamad Medical Corporation, Doha, Qatar. E-mail: ORCID: 0000-0002-3871-7088
| | - Reem El Ajez
- Pharmacy Department, Hamad Medical Corporation, Doha, Qatar. E-mail: ORCID: 0000-0002-3871-7088
| | - Dana Bakdach
- Pharmacy Department, Hamad Medical Corporation, Doha, Qatar. E-mail: ORCID: 0000-0002-3871-7088
| | - Ali Omrani
- Department of Medicine, Hamad Medical Corporation, Doha, Qatar
- College of Medicine, Qatar University, Doha, Qatar
| | - Wanis Ibrahim
- Department of Medicine, Hamad Medical Corporation, Doha, Qatar
- College of Medicine, Qatar University, Doha, Qatar
- Weill Cornell Medicine - Qatar (WCM-Q), Qatar
| | - Rasha El Anany
- Pharmacy Department, Hamad Medical Corporation, Doha, Qatar. E-mail: ORCID: 0000-0002-3871-7088
| | - Moza Al-Hail
- Pharmacy Department, Hamad Medical Corporation, Doha, Qatar. E-mail: ORCID: 0000-0002-3871-7088
| |
Collapse
|
3
|
Zoghbi Y, Barazi R, Abdelkader MH, Eltorki YH, Ghuloum S. First Episode of Psychosis in the Context of Varenicline Treatment for Smoking Cessation. Cureus 2023; 15:e36677. [PMID: 37102012 PMCID: PMC10125011 DOI: 10.7759/cureus.36677] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 02/08/2023] [Indexed: 03/28/2023] Open
Abstract
Smoking is one of the leading causes of preventable death worldwide. Several pharmacological therapies have been established over the years to aid in smoking cessation, including Varenicline, a partial nicotine agonist. Neuropsychiatric adverse events have been reported in patients treated with Varenicline. Here, we present a case of first-episode psychosis in the context of Varenicline therapy. The patient's chart was retrospectively reviewed for relevant medical and psychiatric history, in addition to the use of current or past medications. Routine laboratory investigations and brain imaging were performed. The Naranjo Adverse Drug Reaction Probability Scale was also done independently by two physicians involved in the patient's treatment. He was admitted for psychotic symptoms elicited in the context of a probable adverse reaction to Varenicline. The current evidence linking Varenicline to psychosis remains controversial. Speculatively, there could be a link between Varenicline, which supposedly increases dopamine levels in the prefrontal cortex through the mesolimbic pathways, and psychotic symptoms. It is therefore beneficial to be cognizant, in a clinical setting, of the possibility of the emergence of these symptoms with Varenicline therapy.
Collapse
|
4
|
Sasi S, Faraj H, Barazi R, Kolleri J, Chitrambika P, Rahman Al Maslamani MA, Ali M. Endogenous endophthalmitis due to Serratia marcescens secondary to late-onset empyema Post-Cardiac surgery in an End-Stage renal disease patient on peritoneal dialysis. Clin Case Rep 2023; 11:e6997. [PMID: 36852121 PMCID: PMC9957995 DOI: 10.1002/ccr3.6997] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/27/2022] [Revised: 01/18/2023] [Accepted: 02/12/2023] [Indexed: 02/27/2023] Open
Abstract
Endogenous bacterial endophthalmitis results from bacterial seeding of the eye during bacteremia. A diagnosis of endogenous bacterial endophthalmitis requires clinical findings such as vitritis or hypopyon along with positive blood cultures. Serratia marcescens is the second most common pathogen causing hospital-acquired ocular infections. This report describes a case of endogenous bacterial endophthalmitis caused by S. marcescens in an older adult with end-stage renal disease (ESRD) on peritoneal dialysis, who had late-onset pleural empyema secondary to coronary artery bypass grafting (CABG). A 61-year-old gentleman presented with a two-day history of cloudy vision, black floaters, pain, swelling, and gradual vision loss in his right eye. There was no history of trauma, ocular surgeries, or previous similar episodes. He had myocardial infarction treated with CABG 3 months back. Examination showed a 3 mm hypopyon in the anterior chamber. He had classic signs of endophthalmitis with positive blood cultures for S. marcescens. He was treated with high-dose intravenous meropenem and intravitreal ceftazidime without vitrectomy. Endophthalmitis progressed to complete vision loss in his right eye, requiring evisceration. Endophthalmitis caused by S. marcescens is rare, but long-term outcomes can be severe, causing complete vision loss in about 60% of the patients. It is usually hospital-acquired, and the source can be late-onset empyema several months after cardiac surgery, in an immunocompromised patient. Systemic antibiotics should be supplemented with intravitreal agents with or without pars plana vitrectomy.
Collapse
Affiliation(s)
- Sreethish Sasi
- Infectious Diseases Division, Department of Internal MedicineHamad Medical CorporationDohaQatar
| | - Hazem Faraj
- Department of Internal MedicineHamad Medical CorporationDohaQatar
| | - Raja Barazi
- Department of PharmacyHamad Medical CorporationDohaQatar
| | - Jouhar Kolleri
- Department of Clinical ImagingHamad Medical CorporationDohaQatar
| | - P. Chitrambika
- Department of AnesthesiologyHamad Medical CorporationDohaQatar
| | | | - Maisa Ali
- Infectious Diseases Division, Department of Internal MedicineHamad Medical CorporationDohaQatar
| |
Collapse
|
5
|
Abuyousef S, Alnaimi S, Omar N, Elajez R, Elmekaty E, Arafa E, Barazi R, Ghasoub R, Rahhal A, Hamou F, Al-Amri M, Karawia A, Ajaj F, Alkhawaja R, Kardousha A, Awaisu A, Abou-Ali A, Khatib M, Aboukamar M, Al-Hail M. Characteristics and Early Predictors of Intensive Care Unit Admission among COVID-19 Patients in Qatar. Int J Infect Dis 2022. [PMCID: PMC8884751 DOI: 10.1016/j.ijid.2021.12.062] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
Abstract
Purpose This study aimed to explore the early predictors of intensive care unit (ICU) admission and in-hospital mortality among patients diagnosed with Coronavirus disease (COVID-19). Methods & Materials This was a case-control study of adult patients with confirmed COVID-19. Cases were defined as patients admitted to ICU during the period February 29 - May 29, 2020. For each case enrolled, one control was matched by age and gender. Univariate and multivariate logistic regression models were used to identify the predictors for ICU admission and in-hospital mortality among the COVID‐19 patients. Results A total of 1560 patients with confirmed COVID-19 were included. Each group included 780 patients with a predominant male gender (89.7%) and a median age of 49 years (interquartile range, IQR=18). Predictors independently associated with ICU admission included having cardiovascular disease (CVD) (adjusted odds ratio (aOR)=1.64, 95% confidence interval (CI): 1.16 - 2.32, p= 0.005), diabetes (aOR=1.52, 95% CI: 1.08 - 2.13, p= 0.016), body mass index ≥30 kg/m2 (aOR=1.46, 95% CI: 1.03-2.08, p= 0.034), lymphocytes ≤0.8 × 103/μL (aOR=2.69, 95% CI: 1.80-4.02, p<0.001), aspartate aminotransferase (AST) >120 U/L (aOR= 2.59, 95% CI: 1.53-4.36, p<0.001), ferritin >600 μg/L (aOR=1.96, 95% CI: 1.40-2.74, p<0.001), C-reactive protein (CRP) >100 mg/L (aOR=4.09, 95% CI: 2.81-5.96, p<0.001), and dyspnea (aOR=2.50, 95% CI: 1.77-3.54, p <0.001). Similarly, significant predictors of mortality included CVD (aOR=2.16, 95% CI: 1.32- 3.53, p=0.002), diabetes (aOR=1.77, 95% CI: 1.07-2.90, p=0.025), cancer (aOR=4.65, 95% CI: 1.50-14.42, p= 0.008), lymphocytes ≤0.8 x,103/μL (aOR=2.34, 95% CI: 1.45-3.78, p= 0.001), and AST >120 U/L (aOR= 1.89, 95% CI: 1.04-3.43, p=0.036). Conclusion Having CVD, diabetes, lymphopenia, and increased AST were independent predictors for both ICU admission and in-hospital mortality in patients with COVID-19. In addition, obesity, high ferritin, and CRP levels were also associated with increased risk of ICU admission, while cancer was strongly associated with in-hospital mortality. Early identification and monitoring of patients at risk is essential in planning the level of care needed to prevent delay in medical intervention.
Collapse
|
6
|
Al Hamoud E, Hayder Ahmed S, Alkhiyami D, Barazi R, Alrawi S, Zahrah F, Saad M, Mitwally H, Farfar K, Al Anany R. Post-discharge phone follow-up: a collaboration for optimizing medications management upon transition of care. Journal of Emergency Medicine, Trauma and Acute Care 2022. [DOI: 10.5339/jemtac.2022.qhc.45] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022] Open
Affiliation(s)
- Eman Al Hamoud
- Clinical Pharmacy Section, Pharmacy Department. Al-Wakra Hospital, Hamad Medical Corporation. Doha Qatar E-mail:
| | - Sara Hayder Ahmed
- Clinical Pharmacy Section, Pharmacy Department. Al-Wakra Hospital, Hamad Medical Corporation. Doha Qatar E-mail:
| | - Dania Alkhiyami
- Clinical Pharmacy Section, Pharmacy Department. Al-Wakra Hospital, Hamad Medical Corporation. Doha Qatar E-mail:
| | - Raja Barazi
- Clinical Pharmacy Section, Pharmacy Department. Al-Wakra Hospital, Hamad Medical Corporation. Doha Qatar E-mail:
| | - Safa Alrawi
- Clinical Pharmacy Section, Pharmacy Department. Al-Wakra Hospital, Hamad Medical Corporation. Doha Qatar E-mail:
| | - Farah Zahrah
- Clinical Pharmacy Section, Pharmacy Department. Al-Wakra Hospital, Hamad Medical Corporation. Doha Qatar E-mail:
| | - Mohamed Saad
- Clinical Pharmacy Section, Pharmacy Department. Al-Wakra Hospital, Hamad Medical Corporation. Doha Qatar E-mail:
| | - Hassan Mitwally
- Clinical Pharmacy Section, Pharmacy Department. Al-Wakra Hospital, Hamad Medical Corporation. Doha Qatar E-mail:
| | - Khalifa Farfar
- Internal Medicine Department. Al-Wakra Hospital, Hamad Medical Corporation. Doha Qatar
| | - Rasha Al Anany
- Clinical Pharmacy Section, Pharmacy Department. Al-Wakra Hospital, Hamad Medical Corporation. Doha Qatar E-mail:
| |
Collapse
|
7
|
Abuyousef S, Alnaimi S, Omar NE, Elajez R, Elmekaty EZI, Abdelfattah-Arafa E, Barazi R, Ghasoub R, Rahhal A, Hamou F, Al-Amri MK, Karawia A, Ajaj F, Alkhawaja R, Kardousha A, Awaisu A, Abou-Ali A, Khatib M, AbouKamar M, Al-Hail M. 395. Early Predictors of Intensive Care Unit Admission among COVID-19 Patients in Qatar. Open Forum Infect Dis 2021. [PMCID: PMC8644206 DOI: 10.1093/ofid/ofab466.596] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Background Coronavirus disease (COVID-19) is associated with significant morbidity and mortality. This study aimed to explore the early predictors of intensive care unit (ICU) admission and in-hospital mortality among patients diagnosed with COVID-19. Methods This was a case-control study of adult patients with confirmed COVID-19. Cases were defined as patients admitted to ICU during the period February 29 - May 29, 2020. For each case enrolled, one control was matched by age and gender. Results A total of 1560 patients with confirmed COVID-19 were included. Each group included 780 patients with a predominant male gender (89.7%) and a median age of 49 years (interquartile range = 18). Predictors independently associated with ICU admission were cardiovascular disease (CVD) (adjusted odds ratio (aOR)=1.64, 95% confidence interval (CI): 1.16 - 2.32, p=0.005), diabetes (aOR=1.52, 95% CI: 1.08 - 2.13, p= 0.016), obesity (aOR=1.46, 95% CI: 1.03-2.08, p= 0.034), lymphopenia (aOR=2.69, 95% CI: 1.80-4.02, p< 0.001), high aspartate aminotransferase (AST) (aOR= 2.59, 95% CI: 1.53-4.36, p< 0.001), high ferritin (aOR=1.96, 95% CI: 1.40-2.74, p< 0.001), high C-reactive protein (CRP) (aOR=4.09, 95% CI: 2.81-5.96, p< 0.001), and dyspnea (aOR=2.50, 95% CI: 1.77-3.54, p< 0.001). Similarly, significant predictors of mortality included CVD (aOR=2.16, 95% CI: 1.32- 3.53, p=0.002), diabetes (aOR=1.77, 95% CI: 1.07-2.90, p=0.025), cancer (aOR=4.65, 95% CI: 1.50-14.42, p= 0.008), lymphopenia (aOR=2.34, 95% CI: 1.45-3.78, p= 0.001), and high AST (aOR= 1.89, 95% CI: 1.04-3.43, p=0.036). Risk Factors for ICU admission among patients with COVID-19 (N=1560) ![]()
Conclusion Having CVD, diabetes, lymphopenia, and increased AST were independent predictors for both ICU admission and in-hospital mortality in patients with COVID-19. In addition, obesity, high ferritin, and CRP levels were associated with increased risk of ICU admission, while cancer was strongly associated with in-hospital mortality. Early identification and monitoring of patients at risk is essential in planning the level of care needed to prevent delay in medical intervention. Disclosures Adel Abou-Ali, PharmD, PhD, Astellas Pharma Global Development, Inc. (Employee)
Collapse
Affiliation(s)
- Safae Abuyousef
- Department of Pharmacy, Heart Hospital, Hamad Medical Corporation, Doha, Qatar, Doha, Ad Dawhah, Qatar
| | - Shaikha Alnaimi
- Department of Pharmacy, Hamad Bin Khalifa Medical City, Hamad Medical Corporation, Doha, Ad Dawhah, Qatar
| | - Nabil E Omar
- Pharmacy Department, National center for cancer care and research, Hamad Medical Corporation, Qatar, Doha, Ad Dawhah, Qatar
| | - Reem Elajez
- Hamad Medical Corporation, Doha, Ad Dawhah, Qatar
| | | | | | - Raja Barazi
- Hamad Medical Corporation, Doha, Ad Dawhah, Qatar
| | | | - Ala Rahhal
- Hamad Medical Corporation, Doha, Ad Dawhah, Qatar
| | - Fatima Hamou
- Hamad medical corporation, Doha, Ad Dawhah, Qatar
| | | | | | - Fatima Ajaj
- Home Health Care, Hamad Medical Corporation, Doha, Qatar, doha, Ad Dawhah, Qatar
| | - Raja Alkhawaja
- Department of Pharmacy, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar, Doha, Ad Dawhah, Qatar
| | | | - Ahmed Awaisu
- College of Pharmacy, Qatar University, Doha, Ad Dawhah, Qatar
| | - Adel Abou-Ali
- Astellas Pharma Global Development, Inc., Northbrook, Illinois
| | - Mohamad Khatib
- Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar, Doha, Ad Dawhah, Qatar
| | | | - Moza Al-Hail
- Hamad Medical Corpoartion, Doha, Ad Dawhah, Qatar
| |
Collapse
|
8
|
Alhmoud EN, Barazi R, Fahmi A, Abdu A, Higazy A, ElHajj M. Critical Appraisal of the Clinical Practice Guidelines for the Management of Dyslipidaemias: Lipid Modification to Reduce Cardiovascular Risk: European Society of Cardiology (ESC) and European Atherosclerosis Society (ESC/EAS) 2019 Guidelines. Journal of Pharmaceutical Health Services Research 2020. [DOI: 10.1111/jphs.12371] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
Abstract
Objective
The aim of the study was to assess the quality of the recently published European clinical practice guidelines for the management of dyslipidaemias, utilizing the refined Appraisal of Guidelines for Research & Evaluation tool.
Method
The 2019 European Society of Cardiology and European Atherosclerosis Society Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk was appraised and scored for methodological rigour and transparency by 5 independent appraisers using a validated tool.
Key findings
The guideline scored highest in the domains that evaluated editorial independence (100%) and clarity of presentation (98.6%) and lowest in the domains that addressed stakeholder involvement (55.56%) and rigour of development (63%). Overall the quality of the guideline was high, and all reviewers recommended its use in practice.
Conclusion
The guideline’s overall quality was judged to be high, and all appraisers recommended its use in practice without modifications.
Collapse
Affiliation(s)
- Eman N Alhmoud
- Clinical Pharmacy Services-Pharmacy Department, Al-Wakra Hospital, Al-Wakra, Qatar
| | - Raja Barazi
- Clinical Pharmacy Services-Pharmacy Department, Al-Wakra Hospital, Al-Wakra, Qatar
| | - Amr Fahmi
- Clinical Pharmacy Services-Pharmacy Department, Al-Wakra Hospital, Al-Wakra, Qatar
| | - Abdullah Abdu
- Clinical Pharmacy Services-Pharmacy Department, Al-Wakra Hospital, Al-Wakra, Qatar
| | - Alya Higazy
- Clinical Pharmacy Services-Pharmacy Department, Al-Wakra Hospital, Al-Wakra, Qatar
| | - Maguy ElHajj
- Clinical Pharmacy and Practice Department, College of Pharmacy, Qatar University, Doha, Qatar
| |
Collapse
|
9
|
Sabri A, Dabbous H, Dowli A, Barazi R. The airway in inhalational injury: diagnosis and management. Ann Burns Fire Disasters 2017; 30:24-29. [PMID: 28592930 PMCID: PMC5446904] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Received: 10/05/2016] [Accepted: 12/15/2016] [Indexed: 06/07/2023]
Abstract
It is estimated that 13.000 to 22.000 individuals suffer from inhalational burns each year in the United States alone. Despite these high numbers, inhalational burns remain a major challenge to otolaryngologists. In this paper, a review of literature is presented in order to provide otolaryngologists with a systematic approach to patients with inhalational burns to optimize treatment, cost, morbidity and, most importantly, mortality. For this purpose, a broad PubMed search was conducted. The available literature was found to highlight the importance of airway management in terms of the timing of intubation, method of intubation, trachea-esophageal (TE) fistula formation and TE rupture. It also emphasizes the importance of carbon monoxide intoxication and prompt correction. Drugs such as heparin sulfate, N-acetylcysteine and albuterol have been proven to help in the treatment of patients with inhalational burns, and more research is currently underway with the purpose of developing chelating drugs that scavenge the toxic substances in the smoke before they can damage the airway.
Collapse
Affiliation(s)
- A. Sabri
- Department of Otolaryngology - Head and Neck Surgery, Cleveland Clinic, Abu Dhabi, United Arab Emirates
| | - H. Dabbous
- Medical School, American University of Beirut, Beirut, Lebanon
| | - A. Dowli
- Department of Surgery, Maine Medical Center, Portland, USA
| | - R. Barazi
- Department of Otolaryngology - Head and Neck Surgery, American University of Beirut, Beirut, Lebanon
| |
Collapse
|
10
|
Abstract
BACKGROUND The negative effect of poverty on child health has been well established. However, rapid urbanization in developing countries prompts new research questions relating to socio-cultural practices and other related variables in these settings. OBJECTIVE To examine the association between maternal cultural participation and child health status in impoverished neighbourhoods of Beirut, Lebanon. METHODS A cross-sectional survey of 1241 mothers with children aged less than 5 years was conducted from randomly selected households in three impoverished neighbourhoods of diverse ethnic and religious make-up. The outcome variable was child health status (good/bad) as assessed by the mother. Maternal variables, including cultural participation, education, demographic and environmental/structural factors, were studied. Descriptive statistics and bivariate associations were provided using Pearson's chi-square tests. Unadjusted and adjusted odds ratios were then obtained from binary logistic regression models. RESULTS Two indicators of maternal cultural participation, namely watching entertaining television and attending movies/art exhibitions, were found to be significantly associated with child health status after controlling for other risk factors. The quality of water, the quality of local health services and maternal education were also significantly associated with child health status. Household income, child gender and household dampness had no significant association with child health status in this context. CONCLUSION Maternal cultural participation was a significant predictor of child health status in impoverished urban communities. Improving child health through culturally focused interventions for mothers, especially in deprived areas, may be greatly important.
Collapse
Affiliation(s)
- M Khawaja
- Center for Research on Population and Health, Faculty of Health Sciences, American University of Beirut, Beirut, Lebanon.
| | | | | |
Collapse
|